Advancing Clinico Genomic Trials (ACGT) is an EU co-funded project that develops open-source semantic and grid-based technologies in support of post genomic clinical trials in cancer research. It addresses clinicians bio-researchers as well as software developers providing an open platform where novel and powerful services can be offered and put to use by practitioners in the field.
This article discusses the ACGT’s approach to collecting and dealing with genomic data. It also looks at the ACGT’s ultimate objective providing a unified technological infrastructure which will facilitate the seamless and secure access and analysis of multi-level clinical and genomic data enriched with high-performing knowledge discovery operations and services.
By doing so it is expected that the influence of genetic variation in oncogenesis will be revealed the molecular classification of cancer and the development of individualised therapies will be promoted and finally the in-silico tumour growth and therapy response will be realistically and reliably modelled.
Further information:
Related posts:
- TrialReach Inc. Launches A Groundbreaking Patient-friendly Search Engine For Clinical Trials
- Developing a european grid infrastructure for cancer research: vision, architecture, and services
- Entest BioMedical Strengthens Its Research Capabilities by Adding Clinical Trials Expert Dr. Vladimir Bogin to Its Scientific Advisory Board
- RNCOS Releases a New Report on Clinical Trials Market in Russia
- State Payer Mandates To Cover Cancer Trials Offer Heterogeneous Protection For Patients
Posted in